Invitris vs. Twist Bioscience: From DNA Synthesis to Protein Expression
Twist is the industry standard for writing DNA. Invitris is the platform for turning that DNA into functional proteins and bacteriophages at 10,000x higher efficiency.
Written by Hustlin from public information. Invitris hasn’t joined Hustlin.
The choice between Invitris and Twist Bioscience depends on where you are in your drug discovery pipeline. Twist Bioscience specializes in high-throughput DNA synthesis. Invitris focuses on the next step: a patent-pending platform that converts DNA into synthetic proteins and bacteriophages, bypassing traditional cell-based expression to reduce material costs by 100x.
Where Invitris is strong
- 10,000x more efficient at creating new biological drugs compared to legacy methods.
- 100x lower material costs for protein and phage production.
- Patent-pending technology platform featured in Science magazine.
- Specialized application for synthetic bacteriophages to combat antibiotic-resistant infections.
- Radically simplifies the workflow from DNA sequence to functional protein.
Where Twist Bioscience is strong
- Industry-leading silicon-based DNA synthesis platform for high-scale oligo and gene production.
- Extensive portfolio including NGS tools and biopharma libraries.
- Proven reliability and massive scale for custom DNA manufacturing.
Side-by-side comparison
| Category | Invitris | Twist Bioscience | Edge |
|---|---|---|---|
| Primary Output | Synthetic proteins and phages | Synthetic DNA and oligos | Neck-and-neck |
| Production Efficiency | >10,000x improvement | High-throughput synthesis | Stronger |
| Material Costs | <100x lower costs | Standard market rates | Stronger |
| Core Technology | Cell-free protein platform | Silicon-based DNA writing | Neck-and-neck |
| Scientific Validation | Featured in Science magazine | Publicly traded industry standard | Neck-and-neck |
| Target Application | Bacteriophages and drug discovery | Genomics and library prep | Neck-and-neck |
Which one should you pick?
Choose Invitris when you need to rapidly express proteins or bacteriophages from DNA templates with minimal overhead and maximum efficiency.
Choose Twist Bioscience when your primary requirement is high-quality, large-scale custom DNA synthesis or NGS library construction.
Frequently asked questions
Is Invitris better than Twist Bioscience?
They serve different stages of the biological workflow. Twist is better for writing DNA sequences, while Invitris is better for turning those sequences into functional proteins or bacteriophages.
How is Invitris different from Twist?
Twist focuses on DNA synthesis. Invitris uses a patent-pending platform to convert DNA into synthetic proteins, making the drug creation process 10,000x more efficient.
When should I use Invitris over Twist?
Use Invitris when you have a DNA design and need to produce the actual protein or phage, especially if you want to avoid the high costs and slow speeds of traditional cell-based expression.
Can I use Invitris and Twist together?
Yes. Many operators use Twist to synthesize their custom DNA sequences and then use Invitris to express those sequences into proteins or bacteriophages.
Does Invitris replace DNA synthesis?
No. Invitris replaces the traditional, inefficient methods of protein expression and phage production that typically follow the DNA synthesis step.
Simplify your drug discovery pipeline.
Turn DNA into synthetic proteins 10,000x more efficiently with Invitris.
Explore InvitrisBuilding something?
Create a free Hustlin account. Your first Ship Day includes a campus invite, a blog post, and social posts with real URLs.
Create your free account